CIK 0001314102 · Non-accelerated filer<br>Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262774444
- Phone
- 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- Open-market buys, last 90 days
- $52,258
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$52,258. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-03 | GUYER DAVID R Director | Option exercise 10b5-1 | +6,525 | $3.26 | $21K | 12,075 |
| 2024-06-03 | GUYER DAVID R Director | Option exercise 10b5-1 | +3,250 | $3.50 | $11K | 15,325 |
| 2024-06-03 | GUYER DAVID R Director | Sale 10b5-1 | −11,625 | $10.30 | $120K | 3,700 |
| 2024-06-03 | GUYER DAVID R Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,250 | 6,500 | ||
| 2024-06-03 | GUYER DAVID R Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,525 | 13,050 | ||
| 2024-05-25 | Elston George Chief Financial Officer | Option exercise | +7,500 | 51,107 | ||
| 2024-05-25 | Elston George Chief Financial Officer | Shares withheld for taxes | −3,627 | $11.16 | $40K | 47,480 |
| 2024-05-25 | Elston George Chief Financial Officer | Option exercise · Restricted Stock Units | −7,500 | 15,000 | ||
| 2024-05-14 | GUYER DAVID R Director | Option exercise 10b5-1 | +6,525 | $3.26 | $21K | 13,925 |
| 2024-05-14 | GUYER DAVID R Director | Option exercise 10b5-1 | +3,250 | $3.50 | $11K | 17,175 |
| 2024-05-14 | GUYER DAVID R Director | Sale 10b5-1 | −11,625 | $12.65 | $147K | 5,550 |
| 2024-05-14 | GUYER DAVID R Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,250 | 9,750 | ||
| 2024-05-14 | GUYER DAVID R Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,525 | 19,575 | ||
| 2024-05-06 | Cormorant Asset Management, LP 10% owner | Purchase | +642,847 | $11.70 | $7.5M | 8,117,847 |
| 2024-05-06 | Cormorant Asset Management, LP 10% owner | Purchase | +207,153 | $12.36 | $2.6M | 8,325,000 |
| 2024-04-18 | Cormorant Asset Management, LP 10% owner | Purchase | +395,244 | $17.62 | $7.0M | 7,288,479 |
| 2024-04-18 | Cormorant Asset Management, LP 10% owner | Purchase | +186,521 | $18.90 | $3.5M | 7,475,000 |
| 2024-03-30 | Paggiarino Dario A. Chief Medical Officer | Option exercise | +5,834 | 48,056 | ||
| 2024-03-30 | Paggiarino Dario A. Chief Medical Officer | Option exercise | +30,570 | 78,626 | ||
| 2024-03-30 | Paggiarino Dario A. Chief Medical Officer | Option exercise | +14,000 | 92,626 |
Page 10 of 18 · 352 trades